Dark Forest Capital Management’s Corcept Therapeutics CORT Stock Holding History

Dark Forest Capital Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.52M	Buy	28,982 +7,533	+35%	+$455K	0.16%	210
2026 Q1	$865K	Buy	+21,449	New	+$802K	0.08%	411
2025 Q3	–	Sell	-3,379	Closed	-$248K	–	1212
2025 Q2	$248K	Buy	3,379 +205	+6%	+$14.9K	0.01%	1055
2025 Q1	$363K	Buy	+3,174	New	+$193K	0.02%	1017
2024 Q4	–	Sell	-6,156	Closed	-$285K	–	1004
2024 Q3	$285K	Buy	+6,156	New	+$219K	0.04%	655
2023 Q4	–	Sell	-19,384	Closed	-$528K	–	595
2023 Q3	$528K	Buy	+19,384	New	+$561K	0.04%	695
2023 Q1	–	Sell	-1,524	Closed	-$31K	–	1214
2022 Q4	$31K	Buy	+1,524	New	+$38.2K	0.01%	476
2021 Q3	–	Sell	-10,064	Closed	-$221K	–	1307
2021 Q2	$221K	Buy	+10,064	New	+$224K	0.1%	158

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dark Forest Capital Management's CORT Position: Q2 2026 in Review

Dark Forest Capital Management increased its Corcept Therapeutics (CORT) stake by 35% in Q2 2026, buying an estimated $455K and bringing the position to 28,982 shares worth $2.52M. The position accounts for 0.16% of the portfolio, ranked #210.

Dark Forest Capital Management first reported a position in CORT in Q2 2021 and has held it in 8 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Dark Forest Capital Management held 28,982 shares of Corcept Therapeutics worth $2.52M as of Q2 2026.
Dark Forest Capital Management bought 7,533 Corcept Therapeutics shares in Q2 2026, an estimated $455K.
Corcept Therapeutics made up 0.16% of Dark Forest Capital Management's portfolio in Q2 2026, its #210 holding.
Dark Forest Capital Management first reported a position in Corcept Therapeutics in Q2 2021 and has held it in 8 quarters since.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.